Clinical Trial Update: Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial investigating dasatinib combined with ifosfamide, carboplatin, and etoposide in young patients with metastatic or recurrent malignant soli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors
• Childhood Germ Cell Tumor
• Extragonadal Germ Cell Tumor
• Kidney Cancer
• Liver Cancer
• Lymphoma
• Neuroblastoma
• Ovarian Cancer
• Sarcoma
• Testicular Germ Cell Tumor
• Unspecified Childhood Solid Tumor Protocol Specific

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DASATINIB (Dasatinib)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-04-27